Heart Failure in Type 2 Diabetes – Early Identification and Collaboration for Improving Patient Outcomes

This independent medical education symposium is endorsed by University of Glasgow and sponsored by an unrestricted educational grant from AstraZeneca and Roche diagnostic.

17:00 – 17:05Welcome and introductionsShelley Zieroth (CAN)
17:05 – 17:20HF in T2D: Perspectives from a diabetologist and a cardiologistAntonio Ceriello (ITA)
Shelley Zieroth (CAN)
17:20 – 17:30NT-proBNP – the gold-standard biomarker for screening and diagnosis of HFAntoni Bayes-Genis (ESP)
17:30 – 17:40Time to act – SGLT2 inhibitors in HFMark Petrie (UK)
17:40 – 17:50Case studyMark Petrie (UK)
Naveed Sattar (UK)
17:50 – 18:00Panel discussion and live Q&AAll faculty

Organised by CHANGE IME